Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Simvastatin stimulates apoptosis in cholangiocarcinoma by inhibition of Rac1 activity.

Miller T, Yang F, Wise CE, Meng F, Priester S, Munshi MK, Guerrier M, Dostal DE, Glaser SS.

Dig Liver Dis. 2011 May;43(5):395-403. doi: 10.1016/j.dld.2011.01.010. Epub 2011 Feb 21.

2.

Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression.

Fava G, Demorrow S, Gaudio E, Franchitto A, Onori P, Carpino G, Glaser S, Francis H, Coufal M, Marucci L, Alvaro D, Marzioni M, Horst T, Mancinelli R, Benedetti A, Alpini G.

Liver Int. 2009 Aug;29(7):1031-42. doi: 10.1111/j.1478-3231.2009.01997.x. Epub 2009 Mar 9.

3.

Secretin inhibits cholangiocarcinoma growth via dysregulation of the cAMP-dependent signaling mechanisms of secretin receptor.

Onori P, Wise C, Gaudio E, Franchitto A, Francis H, Carpino G, Lee V, Lam I, Miller T, Dostal DE, Glaser SS.

Int J Cancer. 2010 Jul 1;127(1):43-54. doi: 10.1002/ijc.25028.

4.

Apoptosis of human cholangiocarcinoma cell lines induced by β-escin through mitochondrial caspase-dependent pathway.

Shen DY, Kang JH, Song W, Zhang WQ, Li WG, Zhao Y, Chen QX.

Phytother Res. 2011 Oct;25(10):1519-26. doi: 10.1002/ptr.3435. Epub 2011 Mar 11.

PMID:
21394804
5.
6.

FTY720 inhibits proliferation and epithelial-mesenchymal transition in cholangiocarcinoma by inactivating STAT3 signaling.

Lu Z, Wang J, Zheng T, Liang Y, Yin D, Song R, Pei T, Pan S, Jiang H, Liu L.

BMC Cancer. 2014 Oct 25;14:783. doi: 10.1186/1471-2407-14-783.

7.

Downregulation of ROS-FIG inhibits cell proliferation, colony‑formation, cell cycle progression, migration and invasion, while inducing apoptosis in intrahepatic cholangiocarcinoma cells.

Deng G, Hu C, Zhu L, Huang F, Huang W, Xu H, Nie W.

Int J Mol Med. 2014 Sep;34(3):661-8. doi: 10.3892/ijmm.2014.1823. Epub 2014 Jun 27.

8.
9.

Simvastatin enhances the chemotherapeutic efficacy of S-1 against bile duct cancer: E2F-1/TS downregulation might be the mechanism.

Cai JP, Chen W, Hou X, Liang LJ, Hao XY, Yin XY.

Anticancer Drugs. 2013 Nov;24(10):1020-9. doi: 10.1097/CAD.0b013e328364f935.

PMID:
23941814
10.

H3 histamine receptor-mediated activation of protein kinase Calpha inhibits the growth of cholangiocarcinoma in vitro and in vivo.

Francis H, Onori P, Gaudio E, Franchitto A, DeMorrow S, Venter J, Kopriva S, Carpino G, Mancinelli R, White M, Meng F, Vetuschi A, Sferra R, Alpini G.

Mol Cancer Res. 2009 Oct;7(10):1704-13. doi: 10.1158/1541-7786.MCR-09-0261. Epub 2009 Oct 13.

11.

Effect of transforming growth factor-beta1 on human intrahepatic cholangiocarcinoma cell growth.

Shimizu T, Yokomuro S, Mizuguchi Y, Kawahigashi Y, Arima Y, Taniai N, Mamada Y, Yoshida H, Akimaru K, Tajiri T.

World J Gastroenterol. 2006 Oct 21;12(39):6316-24.

12.

Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines.

Xu L, Hausmann M, Dietmaier W, Kellermeier S, Pesch T, Stieber-Gunckel M, Lippert E, Klebl F, Rogler G.

BMC Cancer. 2010 Jun 18;10:302. doi: 10.1186/1471-2407-10-302.

13.

Triptolide and TRAIL combination enhances apoptosis in cholangiocarcinoma.

Clawson KA, Borja-Cacho D, Antonoff MB, Saluja AK, Vickers SM.

J Surg Res. 2010 Oct;163(2):244-9. doi: 10.1016/j.jss.2010.03.067. Epub 2010 Apr 25.

14.

Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinoma.

Francis H, DeMorrow S, Venter J, Onori P, White M, Gaudio E, Francis T, Greene JF Jr, Tran S, Meininger CJ, Alpini G.

Gut. 2012 May;61(5):753-64. doi: 10.1136/gutjnl-2011-300007. Epub 2011 Aug 26.

15.

Arsenic trioxide inhibits cholangiocarcinoma cell growth and induces apoptosis.

Zhong F, Zhang S, Shao C, Yang J, Wu X.

Pathol Oncol Res. 2010 Sep;16(3):413-20. doi: 10.1007/s12253-009-9234-1. Epub 2009 Dec 12.

PMID:
20012722
16.

Capsaicin treatment attenuates cholangiocarcinoma carcinogenesis.

Wutka A, Palagani V, Barat S, Chen X, El Khatib M, Götze J, Belahmer H, Zender S, Bozko P, Malek NP, Plentz RR.

PLoS One. 2014 Apr 18;9(4):e95605. doi: 10.1371/journal.pone.0095605. eCollection 2014.

17.

XIAP antagonist embelin inhibited proliferation of cholangiocarcinoma cells.

Wehrkamp CJ, Gutwein AR, Natarajan SK, Phillippi MA, Mott JL.

PLoS One. 2014 Mar 6;9(3):e90238. doi: 10.1371/journal.pone.0090238. eCollection 2014.

18.

Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosis.

Onori P, DeMorrow S, Gaudio E, Franchitto A, Mancinelli R, Venter J, Kopriva S, Ueno Y, Alvaro D, Savage J, Alpini G, Francis H.

Int J Cancer. 2009 Aug 1;125(3):565-76. doi: 10.1002/ijc.24271.

19.
20.

Prosurvival role of heat shock factor 1 in the pathogenesis of pancreatobiliary tumors.

Dudeja V, Chugh RK, Sangwan V, Skube SJ, Mujumdar NR, Antonoff MB, Dawra RK, Vickers SM, Saluja AK.

Am J Physiol Gastrointest Liver Physiol. 2011 Jun;300(6):G948-55. doi: 10.1152/ajpgi.00346.2010. Epub 2011 Feb 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk